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Our research letter found that circulatory mtDNA level increased after the end of CPB and positive
correlations between mtDNA and peak CRP level, peak BNP level, and peak PCT level, which revealed the
prognostic role of perioperative circulatory mtDNA level in patients who underwent cardiopulmonary
bypass.
 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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Patient basic characteristics, surgery information and laboratory data.
Characteristic N = 46
Age (years) 48.8  10.3
Women 26 (56.5%)
Hypertension 30 (65.2%)
Diabetes 5 (10.9%)
Current smoker 11 (23.9%)
Surgery information
Aortic cross-clamping time (min) 119  21
CPB time (min) 138  18
Laboratory data
Serum creatinine (mmol/L) 0.5  0.2
Total cholesterol (mg/dL) 178.2  38.9
Glucose (mg/dL) 142.1  40.2
CRP (mg/L) 3.5  2.9
BNP (pg/mL) 89  68
PCT (pg/mL) 239  121
mtDNA (copies/mL) 223  23
Variables are presented as mean  SD or as numbers (%). CPB, cardiopul-
monary bypass; CRP, C-reactive protein; BNP, B-type natriuretic peptide;
PCT, procalcitonin; mtDNA, mitochondrial DNA.Cardiopulmonary bypass (CPB) has been widely applied since
1950s, and there are still some indications of harmful effects of
CPB.1 Mitochondrial DNA (mtDNA) fragments, referred as damage-
associated molecular patterns, can lead to a series of molecular
processes causing inﬂammatory responses in several diseases.2 In
the present letter, we focused on clinic demonstrations of the
perioperative circulatory mtDNA level in patients who underwent
cardiac surgery with CPB.
46 consecutive patients were included in our study, who
required surgical double valve replacement (aortic valve and
mitral valve) from June 2014 to December 2014 at West China
Hospital (Chengdu, China). Circulatory levels of mtDNA were
measured by real-time PCR. Brieﬂy, blood samples were collected
at admission (T1), the end of CPB (T2), 6 h postoperation (T3), 12 h
postoperation (T4), and 24 h postoperation (T5). The mtDNA copy
numbers were quantiﬁed with 10-fold serial diluted standard
curves. The forward primer 50-CGAGCAGTAGCCCAAACAAT-30 and
reverse primer 50-TGTGATAAGGGTGGAGAGGTT-30 were used. The
mtDNA levels were compared for well-known biomarkers, such as
C-reactive protein (CRP), B-type natriuretic peptide (BNP), and
procalcitonin (PCT). Informed consent was obtained from every
patient. The study was conducted following the Declaration of
Helsinki and approved by the research committee in the Sichuan
University.
Basic patient characteristics, surgery information, and labora-
tory data are shown in Table 1. All surgeries were performed
successfully with no fatalities and all patients were discharged
from the hospital. Four patients exhibited low output syndrome
and two patients had renal failure after surgery. Circulatory
mtDNA level was signiﬁcantly higher from T2 to T5 than T1
(p < 0.05). These levels peaked at T4 (905  191 copies/mL), at
which point they were signiﬁcantly correlated with peak CRP levels
(r = 0.72, p < 0.01), peak BNP levels (r = 0.638, p < 0.01), and peak PCT
levels (r = 0.588, p < 0.01) (Fig. 1).
It is well known that postoperative inﬂammatory responses
are highly related to the prognosis of cardiac surgery. Accordingly,
we inferred that mtDNA release after cardiac surgery may causehttp://dx.doi.org/10.1016/j.ihj.2016.04.014
0019-4832/ 2016 Cardiological Society of India. Published by Elsevier B.V. This is an 
licenses/by-nc-nd/4.0/)inﬂammatory responses and inﬂuence the prognosis of cardiac
surgery. Furthermore, many studies have illustrated that concen-
trations of CRP, PCT, and BNP are associated with the magnitude of
operative injuries.3 Analyses with peak levels of these known
predictors, weak but signiﬁcant correlations with circulatory
mtDNA level at T4 were detected. The results of the present study
suggest that mtDNA is a promising prognostic predictor of cardiac
surgery with CPB. In fact, mtDNA is already considered as a marker
for predicting oxidative stress in obstructive sleep apnea and
mortality in intensive care patients, and our results suggest an
additional prognostic application of mtDNA.4,5
In the present preliminary study, we found that, after cardiac
surgery with CPB, the circulatory mtDNA level increased and
bivariate correlation analyses demonstrated signiﬁcant correla-
tions between mtDNA level and peak levels of CPR, BNP, and PCT,open access article under the CC BY-NC-ND license. (http://creativecommons.org/
Fig. 1. (A) Variants of perioperative circulatory mtDNA level after cardiac surgery with CPB. *p < 0.05 vs. T1, #p < 0.05 vs. T4, N = 46. (B) Circulatory mtDNA level at T4 was
signiﬁcantly correlated with peak CRP level (r = 0.72, p < 0.01). (C) Circulatory mtDNA level at T4 was signiﬁcantly correlated with peak BNP level (r = 0.638, p < 0.01). (D)
Circulatory mtDNA level at T4 was signiﬁcantly correlated with peak PCT level (r = 0.588, p < 0.01). (T1: at admission; T2: the end of CPB; T3: 6 h postoperation; T4: 12 h
postoperation; T5: 24 h postoperation.)
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mtDNA.
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